ORBCOMM refinances existing debt facility and secures capital to accelerate market leadership
STERLING, Va., April 29, 2026 (GLOBE NEWSWIRE) -- ORBCOMM Inc., a global leader in industrial IoT, today announced the closing of a $460 million refin
global Kamis, 30 Apr 2026 09:03
WillScot Announces Investor Conference Schedule for May and June 2026
SCOTTSDALE, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation ("WillScot" or the "Company") (Nasdaq: WSC), a leader in innovativ
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
For an accessible version of this Press Release, please visit www.tevapharm.com Q1 2026 revenues of ~$4.0 billion
increased by 2% in U.
Kamis, 30 Apr 2026 09:01
Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs
- Eko Vet+TM | CANINEBEAT? AI helps veterinarians detect, visualize, and grade heart murmurs in dogs that can otherwise go undetected- The CANINEBEAT?
Kamis, 30 Apr 2026 09:00
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva's Pivot to Growth Strategy
- Ecopipam, Emalex's investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist wi
Kamis, 30 Apr 2026 08:29
Rhenus completes acquisition of LBH Group and accelerates global maritime growth
Rhenus Group acquires remaining 49 percent of LBH Group, achieving full ownershipPartnership further strengthens global maritime and port logistics ne
Rabu, 29 Apr 2026 16:27
De Beers Group Launches New Bridal Campaign Celebrating Desert Diamonds
NEW YORK, US - Media OutReach Newswire - 29 April 2026 - De Beers Group recently announced the launch of its new Desert diamonds Bridal campaign
Rabu, 29 Apr 2026 16:17
SUNeVision Concludes Third Edition of Startup Programme
Recognising AI Startups to Lead New Momentum in Hong Kong's I&T DevelopmentHONG KONG SAR - Media OutReach Newswire - 29 April 2026 - SUNeVision H
Rabu, 29 Apr 2026 16:01
New Report from the MPA's Content Security Initiative Links Control Failures to Content Security Incidents Across the Entertainment Industry
First-of-its-Kind Industry Analysis from the Trusted Partner Network Reveals Concerning Trends Across Global Entertainment Supply ChainLOS ANGELES, Ap
Rabu, 29 Apr 2026 15:58
Setiap menit sangat berharga: EAACI menyerukan tindakan mendesak untuk memastikan sekolah aman bagi anak-anak yang berisiko mengalami anafilaksis
Di Spanish Congress of Deputies (Kongres Deputi Spanyol), Presiden EAACI Mar?a Jose Torres mendukung manifesto bersama dengan AEPNAA, SEAIC, dan SEICA
Rabu, 29 Apr 2026 14:55
A&A Sports Group LLC Merevolusi Dukungan bagi Atlet melalui Penyediaan Asuransi dan Rekening Pensiun
Pendiri Alander Pulliam Mendorong Perlindungan Menyeluruh bagi Atlet
BIRMINGHAM, Ala., April 28, 2026 (GLOBE NEWSWIRE) -- Dalam langkah penuh terobos
Rabu, 29 Apr 2026 14:43
Anaqua Acquires Patrix to Expand Its IP Management Leadership
Acquisition welcomes nearly 400 IP management software (IPMS) customers into Anaqua's client communityBOSTON, April 28, 2026 (GLOBE NEWSWIRE) --
Rabu, 29 Apr 2026 10:54
Raiffeisenbankengruppe Oesterreich (excluding Raiffeisen Bank International) Selects nCino to Modernise Corporate Lending Across Its Nationwide Network
One of Euro''s largest cooperative banking institutions to standardise lending operations on the nCino PlatformLONDON, April 28, 2026 (GLOBE
Rabu, 29 Apr 2026 10:52
Jay Mondo and A&A Sports Group LLC Unveil Visionary Summer Music Campaign
A Global Fusion of Sonic Artistry, Advocacy, and Concrete Action to Combat Child TraffickingLOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- A&A Sports
Rabu, 29 Apr 2026 10:12
Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial
* In SYNCHRONIZE-1, participants lost up to an average of 39.2 lb (17.8 kg) from baseline after 76 weeks of treatment with survodutide, a glucagon/GLP
